| Ukraine Pharma - New Opportunities for Growth |
Nov, 2008 | Pages : 60 | Price : US$ 800.00 |
| The Ukraine market is expected to grow strongly, exceeding US$ 4.5 Billion in revenues by 2012, despite country’s unstable political environment. |
| |
| Global Pharmaceutical Market Forecast to 2012 |
Oct, 2008 | Pages : 165 | Price : US$ 1800.00 |
| Growing at a CAGR of around 8%, the global pharmaceutical market is forecasted to reach US$ 1043.4 Billion in 2012. North America remains the largest pharmaceutical market. |
| |
| Global Vaccine Market Forecast to 2012 |
Oct, 2008 | Pages : 130 | Price : US$ 2000.00 |
| The global vaccine market is expected to register revenues in excess of US$ 30 Billion by 2012. Cancer vaccines are expected to account for nearly 27% of the total vaccine revenues by 2012. |
| |
| Indian Healthcare - New Avenues for Growth |
Oct, 2008 | Pages : 75 | Price : US$ 800.00 |
| Total healthcare spending in India is expected to grow at a CAGR of 17% between 2007 and 2012. In India, 80% of healthcare payments are still paid out-of-pocket. |
| |
| Market Potential for Hospital Services, Pharmaceuticals and Medical Devices in US |
Sep, 2008 | Pages : 100 | Price : US$ 1000.00 |
| Total healthcare spending in the US is expected to grow at a CAGR of 7% (2007-2012). Around 122 Million Americans are expected to spend over US$ 414 Billion on cardiovascular diseases by 2012. |
| |
| Russian Pharma Sector Analysis |
Sep, 2008 | Pages : 115 | Price : US$ 1100.00 |
| The Russian pharmaceutical market grew 16% in 2007 as compared to 2006. The Russian pharmaceutical market is forecasted to grow at a CAGR of 14.36% by 2012. |
| |
| Asia Pacific Biotechnology Market (2008-2012) |
Aug, 2008 | Pages : 110 | Price : US$ 1600.00 |
| Growing at an estimated CAGR of 15.9% between 2005 and 2007, the value of Asia-Pacific Biotechnology market in 2007 was more than US$ 41 Billion. |
| |
| Booming Pharma Sector in India |
Aug, 2008 | Pages : 100 | Price : US$ 1100.00 |
| Traditional branded generics presently dominate the Indian pharmaceutical market. Between 2007-08 and 2011-12, the Indian pharma market is expected to grow at a CAGR of nearly 16%. |
| |
| Global Cancer Treatment Forecast to 2012 |
Aug, 2008 | Pages : 85 | Price : US$ 1600.00 |
| Growing at a CAGR of 12.3% between 2007 and 2012, the global market for cancer drugs is expected to cross US$ 78 Billion by 2012. |
| |
| China Healthcare Sector Analysis |
Jul, 2008 | Pages : 95 | Price : US$ 1200.00 |
| Total healthcare spending in China is expected to grow robustly at a CAGR of 11% (2007-2012). Around 118 Million shall be above 65 years by 2012 and have several chronic diseases. |
| |
|
|
